Cytek Biosciences Inc.
(CTKB)
undefined
undefined%
At close: undefined
6.21
0.32%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 167.30M | 296.60M | 364.62M | 165.23M | 30.12M |
Short-Term Investments | 95.11M | 44.55M | - | - | - |
Long-Term Investments | 1.60M | 1.60M | - | - | 250.00K |
Other Long-Term Assets | 1.78M | 1.36M | 1.67M | 1.09M | -63.00K |
Receivables | 56.12M | 48.86M | 29.76M | 18.10M | 17.75M |
Inventory | 60.88M | 48.15M | 32.17M | 23.02M | 18.43M |
Other Current Assets | 12.65M | 17.93M | 4.91M | 2.27M | 1.46M |
Total Current Assets | 392.06M | 454.02M | 432.05M | 208.62M | 67.77M |
Property-Plant & Equipment | 29.26M | 27.57M | 5.85M | 2.14M | 1.04M |
Goodwill & Intangibles | 39.27M | 14.47M | 14.88M | 750.00K | 739.00K |
Total Long-Term Assets | 102.40M | 65.46M | 31.65M | 11.36M | 2.60M |
Total Assets | 494.46M | 519.48M | 463.70M | 219.98M | 70.36M |
Account Payables | 3.03M | 4.80M | 3.03M | 2.94M | 2.34M |
Deferred Revenue | 22.70M | 12.99M | 7.08M | 4.29M | 3.47M |
Short-Term Debt | 3.01M | 12.62M | - | 2.77M | - |
Other Current Liabilities | 26.19M | 26.65M | 19.19M | 15.50M | 14.65M |
Total Current Liabilities | 56.23M | 49.04M | 32.16M | 26.54M | 21.04M |
Long-Term Debt | 11.13M | 14.58M | - | - | - |
Other Long-Term Liabilities | 18.91M | 17.18M | 14.95M | 206.01M | 89.24M |
Total Long-Term Liabilities | 45.17M | 44.89M | 24.74M | 209.47M | 91.02M |
Total Liabilities | 101.39M | 93.93M | 56.90M | 236.01M | 112.06M |
Total Debt | 14.14M | 18.09M | - | 2.77M | - |
Common Stock | 131.00K | 135.00K | 126.00K | 23.00K | 21.00K |
Retained Earnings | -29.18M | -17.03M | -18.19M | -22.61M | -42.02M |
Comprehensive Income | -1.27M | -697.00K | 897.00K | 65.00K | -147.00K |
Shareholders Equity | 393.06M | 425.30M | 406.46M | -16.03M | -41.70M |
Total Investments | 96.71M | 44.55M | - | - | 250.00K |